Advanced BioMatrix’s silk solution is approximately 50 mg/mL (5% W/V) of solubilized protein with a molecular weight of approximately 100k Da, available in 20 mL volume. The silk solution is made of 100% fibroin protein that is derived from the domesticatedBombyx morisilkworm. The product is manufactured in a manner to minimize contamination and has a low bioburden but is not considered sterile.
Fibroin protein is the major structural component of the silkworm’s cocoon fiber. Fibroin offers great potential for use in medically related applications due to the high degree of biocompatibility and lack of immune response when implanted within the body. The silk fiber is solubilized into an aqueous fibroin solution, which can then be used as an additive in culture or for producing 3D scaffolds for tissue-engineering related studies.
As with traditional tissue-engineering approaches, the silk scaffolds are typically seededin vitrowith a specific cell type as most cells will adhere to fibroin protein, and then cultured over time to mimic tissue architecture. It has been shown that the silk fibroin protein can be degraded a number of naturally occurring proteolytic enzymes, and is thus a biologically active scaffold unlike other synthetic materials. As a result the silk scaffold material is degraded and remodeled through similar physiological pathways in the body. Silk fibroin protein is composed of both non-essential and essential amino acids, with a particular concentration of alanine and glycine present, and these amino acids are then reabsorbed by the surrounding cells for new tissue regeneration. This is important as silk degradation products do not collect in the local environment to induce a toxicity which is commonly associated with other synthetic and naturally occurring biomaterials.
The ability to produce a variety of forms and formats scaffold types (e.g. coatings, films, sponges, hydrogels, electro-spun fibers, micro/nanospheres, etc.) offers a number of advantages over other biopolymer systems like collagen, chitosan, and alginate that have less variety in processing choices. The silk material properties can then be modified through a variety of processing techniques to change degradation rate, hydrophobicity/hydrophilicity, transparency, mechanical strength, porosity, oxygen permeability, and thermal stability. In this regard, silk proteins represent a class of biopolymers with definable material properties for a given application.
This product is prepared from silk fibroin extracted fromBombyx morisilkworm cocoons and contains a high monomer content with a molecular weight of approximately 100k Da. It is supplied as a ~50 mg/mL (5%) aqueous solution. This product is aseptically processed resulting in a low bioburden but is not considered sterile. If culturing cells using this product, measures should be taken to maintain sterility of cultures such as use of antibiotics.This product is shipped separately on dry ice.
Parameter, Testing, and Method | Silk Fibroin #5154 |
Form | Solution - Slight haziness |
Package Size | 20 mL |
Storage Temperature | -70°C |
Shelf Life | Minimum of 6 months from date of receipt |
Concentration | 40-60 mg/mL |
Purity - SDS PAGE Electrophoresis | Characteristic |
pH | >4.5 |
Bioburden | Low (< 50 CFU's) but not sterile |
Cell Culture Conditions | Antibiotics are recommended |
Endotoxin | < 5.0 EU/mL |
Source | Domesticated Bombyx Mori Silkworm |
Osmolality (mOsmo H20/kg) | <160 |
Molecular Weight (kDa) | 100-150 |
Download the full PDF versionor continue reading below:
Experimental Protocols for Material Processing :
1.Culture Well Coating Procedure:Use these recommendations as guidelines to determine the optimal coating conditions for your culture system.
2.Concentrating Silk Solution:This technique is used if a higher silk concentration is desired. Higher silk concentrations may be important for specific processing techniques or to modify final material properties.
3.Freestanding Silk Films:This processing method produces freestanding silk film materials that can be used for cell culture or in vivo transplantation. Freestanding silk films offer the advantage of easy removal from culture conditions for further sample analysis.
i. Methanol bath incubation:a. Fill dish with 70% methanol and 30% deionized water and mix.b. Place silk film into methanol solution for 10 minutes.c. Remove silk film and rinse with sterile water or appropriate medium.Note :This processing method rapidly produces insoluble silk film material properties that tend to be opaque, more hydrophobic, and have slow degradation rates in situ.
ii. Water-annealing:a. Obtain an emptied lab vacuum desiccator and fill bottom partially with water.b. Place films on shelf above water, cover, and then pull a 25 in Hg vacuum.c. Stop cock the chamber and allow to sit for 4 hours.d. Remove samples from chamber and sterilize with 70% ethanol and then rinse with sterile water or appropriate media. Note: This processing method produces insoluble silk film material properties that tend to be transparent, more hydrophilic, and have fast degradation rates in situ.
4.3D Silk Sponge Scaffolds:This processing method creates 3D porous scaffolds for both in vitro and in vivo applications or in situ implantation. The scaffold pore size and degradability characteristics can also be tuned using the method below.
A. Aliquot silk solution into a desired molding vessel, Teflon is recommended to allow for ease of material removal.
B. For each sample being prepared weigh the necessary amount of salt to maintain a 25:1 ratio of salt to silk weigh.Note: The control over pore size is dictated by the chosen sodium chloride (salt) crystal size. If a defined pore size is preferred use stainless steel sieves to produce a uniform salt crystal size. It is recommended for salt particles that are 750 µm and larger that the silk solution is concentrated to 8% or above.
C. Add the salt slowly to the silk solution while rotating the molds to allow for uniform salt addition. Be sure to carefully remove air bubbles formed from material displacement through mild agitation or tapping on a surface.
D. Cover the mold and allow the solution to sit for 1-2 days at room temperature to allow for silk scaffold formation.
E. After the scaffold has formed remove the mold cover and place samples into a 2-liter beaker of DI water and place on stir plate.
F. Change the water every 8-12 hours for 48 hours.
H. After the washing period remove the formed scaffolds from the mold and place in a final deionized water rinse for 24 hours to ensure complete removal of residual salt.
I. Scaffolds can be stored in deionized water for at 4 °C or dry at room temperature until needed.
J. The scaffolds can be cut to the required dimensions and steam sterilized before using
5. 3D Silk Hydrogels:This processing method can be used to produce silk hydrogels for use as an injectable biomaterial, in vitro culture, and in vivo use.
A. Place the 5% silk solution into the desired molding vessel or vial.
B. Secure the vessel or vial to a lab vortexer with tape in an upright position.
C. Vortex the solution for a several minutes and at maximal rotational speed. These parameters will need to be optimized for the given silk solution volume and mold geometry.
Note: As an example, pipette 1 mL of silk solution in a glass vial and vortex for ~7 min at 3,200 RPM. The solution should increase in turbidity indicating the gelation process has been initiated.
Note: Once the solution has been vortexed, do not transfer the solution to a secondary container before gelation has completed.
D. Place the vortexed silk/molding vessel/vial in a 37 °C incubator overnight to expedite gelation time.
E. Silk hydrogels can be used for future use as long as they remain hydrated and stored in deionized water at 4 °C.
The silk fibroin contains a fair number of aspartic (0.5 mol%, ~25 residues) and glutamic acids (0.6 mol%, ~30 residues),as well as a small number of lysine residues (0.2 mol%, ~12 residues).
We use the dry down method. (Weigh out a certain amount of silk fibroin and leave in a 60C oven overnight, and weigh the left-over protein).
The silk we supply is a partially hydrolyzed silk fibroin II solution. Whole cocoons, harvested from domesticated Bombyx mori in China, are degummed and processed into a liquid protein solution using heavy inorganic salts. The solution is then desalted, tested, and packaged. One of the key features of our silk fibroin solution is the preservation of the fibroin light chain at around 25 kDa as shown on the gel.
Prepare 1- 2 Liters of 10% wt./vol. PEG solution and then dialyze the 5% fibroin solution overnight in a 3 kDa dialysis cassette overnight (~12 hrs). This should get you to between 10% - 15% fibroin.
Otherwise, the 'quick and dirty' way to do this is allow the water to evaporate from the Silk Fibroin 5% solution in a clean bench. You can dispense the Silk Fibroin solution into a large weigh dish to increase the evaporative surface and then check the dry weight of the fibroin protein periodically. This method can concentrate the solution significantly by the end of the work day.
The Silk Fibroin Protein that we offer is in the ‘regenerated’ form. This material is derived from the silk worm cocoon and then processed and solubilized into an aqueous form.
The silkis a partially hydrolyzed solution of fibroin heavy and light chain proteins. There will be some free amino acids present due to this hydrolysis, but the large majority of the material consists of the former two elements (heavy and light chains).
The silk solution is made from de-sericinized (or degummed it is sometime called) silk fiber. We remove the sericin via our extraction process.
Yes.
A coating allowed to air dry, or a shorter (15-30 minutes) water annealing.
While the native fibroin proteins exist in a 6:6:1 ratio, this composition is almost certainly not preserved during the manufacturing process that are used to create aqueous fibroin solution. This is because the heavy and light chains of fibroin have considerably different amino acid composition and hydrophobicity, rendering them unequally prone to hydrolysis during sericin degumming. This can be seen on the electrophoretic gel from the solution, where the heavy chain is seen as a smear, but the light chain is a relatively preserved band. We have not endeavored into determining the extent of p25 hydrolysis.
Yes.
It is best to maintain the product between -20 and -70 C. Any unused solution should be divided into smaller aliquots and frozen. Try to thaw/refreeze as few times as possible.
The 5% solution has a viscosity of ~12cp. When diluted in water to 2.5%, the viscosity is ~6cp.
References using Silk Fibroin from Advanced BioMatrix
Compaan, Ashley M., Kyle Christensen, and Yong Huang. "Inkjet bioprinting of 3D silk fibroin cellular constructs using sacrificial alginate."ACS Biomaterials Science & Engineering8 (2016): 1519-1526.
Jiang, Bojing, et al. "Water‐Based Photo‐and Electron‐Beam Lithography Using Egg White as a Resist."Advanced Materials Interfaces7 (2017): 1601223.
Liew, Lawrence J., Richard M. Day, and Rodney J. Dilley. "Tympanic membrane organ culture using cell culture well inserts engrafted with tympanic membrane tissue explants."BioTechniques3 (2017): 109-114.
Jativa, Fernando, and Xuehua Zhang. "Transparent silk fibroin microspheres from controlled droplet dissolution in a binary solution."Langmuir31 (2017): 7780-7787.
Maghdouri-White, Yas, et al. "Mammary epithelial cell adhesion, viability, and infiltration on blended or coated silk fibroin–collagen type I electrospun scaffolds."Materials Science and Engineering: C43 (2014): 37-44.
Choi, Moonhyun, Daheui Choi, and Jinkee Hong. "Multilayered controlled drug release silk fibroin nano-film by manipulating secondary structure."Biomacromolecules(2018).
Other references using Silk Fibroin:
Panilaitis B, Altman G, Chen J, Jin H, Karageorgiou V, Kaplan D. Macrophage responses to silk. Biomaterials. 2003;24(18):3079–85.
Meinel L, Hofmann S, Karageorgiou V, Kirker-Head C, McCool J, Gronowicz G, et al. The inflammatory responses to silk films in vitro and in vivo. Biomaterials. 2005;26(2):147–55.
Wang Y, Rudym D, Walsh A, Abrahamsen L, Kim H, Kim H, et al. In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials. 2008;29(24-25):3415–28.
Kim U, Park J, Kim HJ, Wada M. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials. 2005.
Horan R, Antle K, Collette A, Wang Y, Huang J, Moreau J, et al. In vitro degradation of silk fibroin. Biomaterials. 2005;26(17):3385–93.
Li M, Ogiso M, Minoura N. Enzymatic degradation behavior of porous silk fibroin sheets. Biomaterials. 2003;24(2):357–65.
Desjardins M. Phagocytosis: at the crossroads of innate and adaptive immunity. Annu Rev Cell Dev Biol. 2005.
Onuki Y, Bhardwaj U. A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response. J Diabetes Science and Technology. 2008.
Motta A, Fambri L, Migliaresi C. Regenerated silk fibroin films: thermal and dynamic mechanical analysis. Macromolecular Chemistry and Physics. 2002;203(10-11):1658–65.
Agarwal N, Hoagland D, Farris R. Effect of moisture absorption on the thermal properties of Bombyx mori silk fibroin films. Journal of Applied Polymer Science. 1997;63(3):401–10.
Jin H, Park J, Valluzzi R, Cebe P, Kaplan D. Biomaterial films of Bombyx mori silk fibroin with poly (ethylene oxide). Biomacromolecules. 2004;5(3):711–7.
Tretinnikov O, Tamada Y. Influence of casting temperature on the near-surface structure and wettability of cast silk fibroin films. Langmuir. 2001;17(23):7406–13.
DuFort CC, Paszek MJ, Weaver VM. Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol. Nature Publishing Group; 2011 May;12(5):308–19.
Califano JP, Reinhart-King CA. A Balance of Substrate Mechanics and Matrix Chemistry Regulates Endothelial Cell Network Assembly. Cel Mol Bioeng. 2008 Oct 15;1(2-3):122–32.
Reinhart-King CA. How Matrix Properties Control the Self-Assembly and Maintenance of Tissues. Annals of Biomedical Engineering. 2011 Apr 14;39(7):1849–56.
Rice W, Firdous S, Gupta S, Hunter M, Foo C, Wang Y, et al. Non-invasive characterization of structure and morphology of silk fibroin biomaterials using non-linear microscopy. Biomaterials. 2008;29(13):2015–24.
Lawrence BD, Pan Z, Weber MD, Kaplan DL, Rosenblatt MI. Silk film culture system for in vitro analysis and biomaterial design. J Vis Exp. 2012;(62):e3646.
Lawrence B, Cronin-Golomb M, Georgakoudi I, Kaplan D, Omenetto F. Bioactive silk protein biomaterial systems for optical devices. Biomacromolecules. 2008;9(4):1214–20.
Omenetto F, Kaplan D. A new route for silk. Nature Photonics. 2008;2(11):641–3.
Rockwood DN, Preda RC, Yücel T, Wang X, Lovett ML, Kaplan DL. Materials fabrication from Bombyx mori silk fibroin. Nature protocols. Nature Publishing Group; 2011;6(10):1612–31.
Yucel T, Cebe P, Kaplan DL. Vortex-Induced Injectable Silk Fibroin Hydrogels. Biophysical Journal. 2009 Oct;97(7):2044–50.
Safety Data Sheet
Certificate of Origin
This product is for R&D use only and is not intended for human or other uses. Please consult the Material Safety Data Sheet for information regarding hazards and safe handling practices.
Advanced BioMatrix不断丰富已有产品线,目前可为三维细胞培养提供各种胶原蛋白、纤连蛋白、玻连蛋白、水性凝胶、不同粘度与分子量的透明质酸以及低代成纤维细胞等。在美国全部产品授权Sigma销售。
Advanced BioMatrix是组织培养,细胞分析和细胞增殖三维(3D)应用的生命科学领域的领导者。 我们的产品被公认为纯度,功能性和一致性的标准。
我们在生产,分离,纯化,冷冻干燥,细胞培养和蛋白质测试,粘附肽,附着因子,底物刚性和其他3D矩阵产品方面拥有丰富的专业知识。 我们的专业技术和知识正在被用来确保我们的产品质量最高,批次之间一致且易于为我们的研究客户使用。